Anakinra for the treatment of hemophagocytic lymphohistiocytosis: 21 cases

HIGHLIGHTS

• who: Clara Baverez et al. from the , France Research on Healthcare Performance (RESHAPE), INSERM, University Claude Bernard , have published the paper: Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases, in the Journal: (JOURNAL)
• what: The authors aimed to analyse the efficacy and safety of anakinra for the treatment of all-cause sHLH. The first reason is probably the lack of recognition of sHLH as a per se entity requiring specific treatment (i.e., as an aggravating condition), with the attention of physicians being focused on treating the underlying cause.
• how: The authors . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.